Irving-based Kimberly-Clark announced a blockbuster deal Monday morning to acquire consumer healthcare company Kenvue for nearly $50 billion.

Kimberly-Clark, one of the largest companies in Dallas-Fort Worth, is behind Kleenex, Cottonelle, Huggies and more recognizable brands. It also makes specialized products for use in sensitive environments like laboratories.

When Kenvue joins — expected to close in the second half of 2026 pending regulatory approval —it will bring even more household names under one roof. Here are some things to know about Kenvue:

What does Kenvue make?

Brands Kenvue owns include:

• Aveeno
• Band-Aid
• Benadryl
• Clean & Clear
• Johnson’s Baby
• Listerine
• Lubriderm
• Motrin
• Neosporin
• Neutrogena
• Nicorette
• Pepcid
• Rogaine
• Sudafed
• Tylenol
• Visine
• Zyrtec

It also owns a variety of other consumer health products.

What is Kenvue?

Kenvue was originally the consumer healthcare division of pharmaceutical and biotech giant Johnson & Johnson.

In 2021, Johnson & Johnson announced it would spin off the division as its own company to focus on the more lucrative pharmaceutical and medical device sectors. That year, those sectors reached about $77 billion, while consumer products made up about $15 billion in revenue, according to a New York Times article about the move.

The new separate company, Kenvue, did an initial public offering of stock in 2023, with a total market capitalization of $41 billion.

It has over 20,000 employees globally, and did $15.5 billion in revenue in 2024, with products sold in nearly every country.

Where is Kenvue based?

Kenvue was headquartered in Skillman, N.J., near its former parent company Johnson & Johnson’s New Brunswick headquarters.

It has been slowly relocating its headquarters to Summit, N.J., which puts it closer to New York City.

Kenvue will still maintain a “significant presence” in its New Jersey offices following its acquisition by Kimberly-Clark, according to the announcement.

How has Kenvue dealt with the Trump Administration’s attacks on Tylenol?

Recently, President Donald Trump and his administration linked the use of acetaminophen, including Tylenol, during pregnancy to growing rates of autism.

Trump, alongside health secretary Robert F. Kennedy Jr. and Dr. Mehmet Oz, head of the Centers for Medicare and Medicaid Services, made the announcement in September. The U.S. Food and Drug Administration began the process of changing the safety label for acetaminophen products.

Texas Attorney General Ken Paxton joined in last week, suing Kenvue for allegedly hiding autism risk.

Throughout this controversy, Kenvue has maintained that Tylenol is safe when used as directed, and said that Paxton’s suit “lack[s] legal merit and scientific support.”

Medical professionals and groups largely agree on the safety of Tylenol, especially when used under a doctor’s supervision, and research has not shown that Tylenol or other acetaminophen products cause autism.

In September, the American College of Obstetricians and Gynecologists posted on social media that acetaminophen is a “safe, trusted option for pain relief during pregnancy.”

Fevers, which Tylenol can be used for, pose harm to pregnant women and their babies when left untreated.